Welcome
Support Centre
21 November 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A comparative pharmacokinetic study: 5 Fluorouracil (5FU) provided as patient specific individual doses and as standard doses according to a "dose banding" principle
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN46112469
Date ISRCTN assigned30/09/2005
Local reference number(s)N0436118084
Public titleA comparative pharmacokinetic study: 5 Fluorouracil (5FU) provided as patient specific individual doses and as standard doses according to a "dose banding" principle
Scientific title
AcronymN/A
Disease/condition/study domainCancer: Breast
Study hypothesisThe main aim of the project is to evaluate the concept of dose-binding chemotherapy drugs as a means of improving pharmacy efficiency and reducing patients waiting times. This study aims to compare the plasma profiles of the drug 5FU in breast cancer patients receiving dose-banded and the usual, individually prepared, doses as part of their normal FEC chemotherapy regimen.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaAll study participants will be women with breast cancer who are receiving adjuvant therapy.
Participants - exclusion criteriaPatients on reduced doses of FEC chemotherapy, with known liver metastases, who have received chemotherapy for previous malignancies.
Patient information material
Anticipated start date01/03/2002
Anticipated end date01/03/2007
Status of trialCompleted
Target number of participants26
InterventionsRandomised controlled trial
Primary outcome measure(s)The comparative plasma concentration profiles (Cmax, AUC) in patients receiving dose-banded and individually prepared doses of 5 Fluorouracil.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingLeeds Teaching Hospitals NHS Trust
NHS R&D Support Funding
Sponsor nameRecord Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameMs V A Walker
Contact detailsDepartment of Medical Oncology
Level 4
Gledhow Wing
St James's University Hospital
Leeds
United Kingdom
LS9 7TF
Contact telephone+44 (0)113 243 3144
Contact fax+44 (0)113 242 6496
Contact emailr&d@leedsth.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN46112469
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central